CDC study on doxy PEP using Truveta Data

The Centers for Disease Control and Prevention published an important new study using Truveta Data to examine how doxycycline postexposure prophylaxis (doxy PEP) is being prescribed in real-world care. The research found that existing ICD-10 codes don’t reliably capture doxy PEP use—making it difficult to monitor adoption and outcomes. The authors highlight the need for a dedicated code to track this new STI prevention tool. Another great example of how real-world data can inform both public health and regulatory decisions. Learn more: https://tr.vet/4hj2PbJ

The Centers for Disease Control and Prevention published an important new study using Truveta Data to examine how doxycycline postexposure prophylaxis (doxy PEP) is being prescribed in real-world care. The research found that existing ICD-10 codes don’t reliably capture doxy PEP use—making it difficult to monitor adoption and outcomes. The authors highlight the need for a dedicated code to track this new STI prevention tool. Another great example of how real-world data can inform both public health and regulatory decisions. Learn more: https://tr.vet/4hj2PbJ

Excited to see Truveta Data power new public health insights from the Centers for Disease Control and Prevention. Their research highlights the need for better tracking of doxycycline postexposure prophylaxis (doxy PEP)—a new tool to prevent bacterial STIs. By using de-identified, linked EHR data from 1 in 3 Americans, CDC researchers demonstrated how real-world evidence can reveal important gaps in adoption and monitoring of emerging prevention strategies. Dive into the findings: https://tr.vet/4hj2PbJ

Federally Qualified Health Centers (FQHCs) are leading the way in guideline-adherent kidney disease testing, even while serving socially at-risk populations. The article highlights the critical role FQHCs play in delivering high-quality care and reducing gaps in chronic disease management. Dive into the data and read the study here: #FQHC #kidneydisease #improvinghealthoutcomes # #clinicalguidelines

Federally Qualified Health Centers (FQHCs) are leading the way in guideline-adherent kidney disease testing, even while serving socially at-risk populations. The article highlights the critical role FQHCs play in delivering high-quality care and reducing gaps in chronic disease management. Dive into the data and read the study here: https://lnkd.in/gS2-SDzq #FQHC #kidneydisease #improvinghealthoutcomes # #clinicalguidelines

Federally Qualified Health Centers (FQHCs) are leading the way in guideline-adherent kidney disease testing, even while serving socially at-risk populations. The article highlights the critical role FQHCs play in delivering high-quality care and reducing gaps in chronic disease management. Dive into the data and read the study here: https://lnkd.in/gWCd_MvK #FQHC #kidneydisease #improvinghealthoutcomes # #clinicalguidelines

Federally Qualified Health Centers (FQHCs) are leading the way in guideline-adherent kidney disease testing, even while serving socially at-risk populations. The article highlights the critical role FQHCs play in delivering high-quality care and reducing gaps in chronic disease management. Dive into the data and read the study here: https://lnkd.in/ghp8jiQh #FQHC #kidneydisease #improvinghealthoutcomes # #clinicalguidelines

🔬 ASGE Technology Committee Update: Enteral Stents 2025 📚 The ASGE Technology Committee conducts evidence-based reviews of GI endoscopic technologies — combining MEDLINE searches, FDA MAUDE data, and expert input. 🧠 Reports emphasize controlled clinical trials, but also include large case series and expert opinions when RCTs are lacking. 💻 Technical data are gathered from scientific publications, vendor communications, and coding/pricing data to guide real-world use. 🩻 GI stents help maintain patency of natural or artificial lumens across the esophagus, stomach, duodenum, and colon. 🧩 This 2025 report provides an update to the 2011 ASGE review, covering current self-expandable metal stents (SEMSs) used for esophageal, gastroduodenal, and colonic obstruction. ⚖️ ASGE reports are educational, not prescriptive — they guide practice but do not define standards of care. 📈 A valuable resource for endoscopists staying current with evolving stent technology, safety data, financial, and clinical applications. #ASGE #Endoscopy #Gastroenterology #Innovation #GIStents

The Centers for Disease Control and Prevention reports that sickle cell disease affects nearly 100,000 Americans, but thanks to advanced technology, there are more convenient and accessible testing options close to home. Learn about the basics of symptoms associated with the disease and testing options available through HNL Lab Medicine. ⤵️ https://hnl.llc/6D4BsLC #HNLLabTestsDirect #SickleCellDisease #WellnessResources #HealthcareResources

For PAD (peripheral arterial disease) awareness month, we would like to share one of our most important resources: Chapter 10 of the Best Practice Recommendations (BPRs), entitled Prevention and Management of Peripheral Arterial Ulcers. This is a crucial tool for all health-care providers who want to increase their knowledge about PAD and treating at-risk patients. You can find this asset and many more on our website: https://lnkd.in/eA2AkgEk